Business
Alternate Health Announces US Listing On The OTC, And The Closing Of An Additional $7.5 Million In Funding
Alternate Health Announces US Listing On The OTC, And The Closing Of An Additional $7.5 Million In Funding.
About this update from Alternate Health Corp
[{"type":"text","content":"\n\n\n\nAlternate Health Announces US Listing On The OTC, And The Closing Of An Additional $7.5 Million In Funding\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nAlternate Health Announces US Listing On The OTC, And The Closing Of An Additional $7.5 Million In Funding\nPR Newswire\nPLANO, TX, March 10, 2017\n\n\n\nPLANO, TX, March 10, 2017 /PRNewswire/ - Alternate Health Corp. (CSE:AHG) (OTC:AHGIF) (the \"Company\"), Alternate Health announced today that it has listed its shares for trading on the OTC bulletin board under the ticker symbol AHGIF, joining other top medical cannabis companies like Canopy Growth Corporation (TSX:WEED.TO) and GW Pharmaceuticals (NASDAQ: GWPH) in the largest cannabis market in the world.\n\n\n \n  \n\n \nYesterday, Alternate Health also announced the closing of its recent capitalization of $7,569.055, less a finder's fee of $259,330.50.  The company issued 2,238,940 common shares at a price of $3.25 Canadian ($2.50 US).  The company currently has an on-hand cash position of over $12 million, all common shares issued under this private placement have a 4-month hold period in accordance with regulators and expiring July 7, 2017.  Finders fees will be paid as permitted by the CSE policies and applicable securities laws.\n\n\"We are very excited to introduce the Alternate Health companies to American shareholders, as we have tremendous business interests in the US through our labs and technologies, as well as a growing suite of patented pharmaceutical delivery systems for medical cannabis,\" said Bryan Korba, CEO of Alternate Health Corp.  \"Our laboratory business is very profitable and that serves to fund development of our software and technology, as well as conducting research and obtaining the approvals necessary for our patented delivery systems.\"\n\nAlternate Health (https://youtu.be/HX_qGSlIBjA) will continue to leverage its strengths to grow while conducting ongoing clinical studies that demonstrate the effectiveness of our products and our unique, patented medical cannabis delivery systems.\n\nThrough ong...